Endocrinology Fellowship

Training Experts in Endocrinology

The Beth Israel Deaconess Medical Center/Joslin Diabetes Center Fellowship in Endocrinology, Diabetes and Metabolism recruits three new fellows each year.

The ACGME-accredited fellowship in endocrinology at Beth Israel Deaconess Medical Center (BIDMC) prepares physicians for independent practice and a career in academic medicine and who, in addition to acquiring excellent clinical skills, are also enthusiastic about teaching.

History

Beth Israel Deaconess Medical Center was created in 1996 through a merger of the former Beth Israel Hospital and the former New England Deaconess Hospital. BIDMC maintains a long-standing reputation for compassionate patient care coupled with the most advanced patient therapies.

Today, the 651-bed medical center is a tertiary/quaternary teaching hospital of Harvard Medical School, serving more than half a million patients each year. BIDMC's biomedical research program consistently ranks among the top three in National Institutes of Health funding nationwide. In 2012, BIDMC and Joslin Diabetes Center (JDC) initiated a new clinical relationship. That relationship expanded in 2018, when BIDMC joined the Beth Israel Lahey Health system.

BIDMC and JDC are expanding and improving their long-standing clinical collaboration to provide unparalleled preeminent specialty care for people with diabetes. The two institutions continue their collaboration with existing programs in vascular surgery for diabetes complications; clinical endocrinology; nephrology; mental health; podiatry services; and patient education and training. New emphasis is placed on joint programs for training specialists in the area of diabetes and endocrinology.

BIDMC and JDC continue to develop systems that support more efficient and effective delivery of care, including: a joint inpatient hospital coverage program; a shared electronic clinical information system that streamline medical consults and improve access to treatment specialists; joint protocol development; comprehensive risk assessment and personalized disease management programs based on Joslin's disease management guidelines; and ongoing physician, staff and patient education. Patients will receive the highest quality care for diabetes and its complications.